quinoxalines has been researched along with Hepatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besandre, R; Liu, HW | 1 |
| Asatryan, A; Campbell, A; Chiu, YL; Clifton, J; Dutta, S; Lin, CW; Liu, W; Wang, H | 1 |
1 trial(s) available for quinoxalines and Hepatitis
| Article | Year |
|---|---|
Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of ABT-493: A First-In-Human Study.
Topics: Adult; Aminoisobutyric Acids; Antiviral Agents; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Female; Food-Drug Interactions; Hepatitis; Humans; Lactams, Macrocyclic; Leucine; Male; Middle Aged; Placebo Effect; Proline; Quinoxalines; Sulfonamides | 2017 |
1 other study(ies) available for quinoxalines and Hepatitis
| Article | Year |
|---|---|
Biochemical Basis of Vosevi, a New Treatment for Hepatitis C
Topics: Aminoisobutyric Acids; Antiviral Agents; Carbamates; Cyclopropanes; Drug Combinations; Hepacivirus; Hepatitis; Heterocyclic Compounds, 4 or More Rings; Humans; Lactams, Macrocyclic; Leucine; Macrocyclic Compounds; Proline; Quinoxalines; Serine Proteases; Sofosbuvir; Sulfonamides; Viral Nonstructural Proteins | 2018 |